Results 241 to 250 of about 352,450 (307)
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter +20 more
wiley +1 more source
Novel Bispecific Engagers Targeting the CεmX Domain of mIgE‐Expressing Cells
We developed bispecific TCE & NKCE targeting the CεmX domain of mIgE to eliminate IgE‐producing cells. Both constructs demonstrated potent, specific, dose‐dependent cytotoxicity and selective immune activation in vitro. These results highlight their promise as off‐the‐shelf, potentially curative therapeutics for IgE‐associated allergic diseases ...
Constantin Möller +16 more
wiley +1 more source
IgE, anti-IgE therapy, and regulatory T cells: new paradigms in allergic inflammation. [PDF]
Benito-Villalvilla C +4 more
europepmc +1 more source
Asthma and Allergic Bronchopulmonary Aspergillosis: Understanding, Insights, and State-of-the-Art. [PDF]
Saxena P, Muthu V, Sehgal IS, Agarwal R.
europepmc +1 more source
Optimizing the Functional and Safety Properties of a Marine Allergen: Maillard-Induced Conjugation of Chitosan and Saccharides Attenuates the Allergenicity of Turbot (<i>Scophthalmus maximus</i>) Parvalbumin. [PDF]
Dzadu L +5 more
europepmc +1 more source
AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes. [PDF]
Zydron J +13 more
europepmc +1 more source
Clinical phenotypes and molecular endotypes of chronic urticaria: Linking clinical expression to underlying immune mechanisms. [PDF]
Türk M +13 more
europepmc +1 more source

